Menu
GeneBe

4-56313356-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001393381.1(CRACD):c.514A>G(p.Lys172Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

CRACD
NM_001393381.1 missense

Scores

5
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.46
Variant links:
Genes affected
CRACD (HGNC:29219): (capping protein inhibiting regulator of actin dynamics) Involved in negative regulation of barbed-end actin filament capping. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29257166).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CRACDNM_001393381.1 linkuse as main transcriptc.514A>G p.Lys172Glu missense_variant 7/11 ENST00000682029.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CRACDENST00000682029.1 linkuse as main transcriptc.514A>G p.Lys172Glu missense_variant 7/11 NM_001393381.1 A2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 04, 2023The c.514A>G (p.K172E) alteration is located in exon 7 (coding exon 4) of the KIAA1211 gene. This alteration results from a A to G substitution at nucleotide position 514, causing the lysine (K) at amino acid position 172 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
Cadd
Benign
22
Dann
Uncertain
1.0
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.85
T;T;.;T;T
M_CAP
Benign
0.0093
T
MetaRNN
Benign
0.29
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.99
N;N;N
PrimateAI
Benign
0.35
T
Polyphen
0.93
.;.;P;P;P
Vest4
0.24, 0.23, 0.30
MutPred
0.17
.;Loss of methylation at K172 (P = 0.0443);Loss of methylation at K172 (P = 0.0443);Loss of methylation at K172 (P = 0.0443);.;
MVP
0.25
MPC
1.1
ClinPred
0.91
D
GERP RS
5.5
Varity_R
0.27
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr4-57179522; API